Conferences

Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link

Upcoming Conferences

April 26, 20189:00 AM

Frontiers in Cancer Immunotherapy

This two-day scientific conference will convene experts in oncology and immunology to discuss emerging approaches, challenges, and opportunities faced in the rapidly evolving field of cancer immunotherapy.

June 01, 20181:00 PM

2018 ASCO Meeting

CRI scientists will be presenting at the meeting. We will provide a daily recap of new work coming out of the conference, and we will host a conference panel with experts translating this new research into what this means for patients. 

June 30, 20189:00 AM

Patient Summit - San Francisco

Free half-day Saturday event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy.

September 15, 20189:00 AM

Patient Summit - New York

Free half-day Saturday event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy.

September 15, 201810:00 AM

Patient Summit - Live Stream

Free online event via live video stream for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy.

September 30, 20189:00 AM

2018 International Cancer Immunotherapy Conference

The fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, held in New York City, is devoted to exploring the latest research in cancer immunology and immunotherapy.

October 27, 20189:00 AM

Patient Summit - San Diego

Free half-day Saturday event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy.

Past Conferences

April 14, 20188:00 AM
Conferences

AACR Annual Meeting 2018

Many CRI-funded and -affliated scientists and clinicans will be showcased at the American Association of Cancer Research Annual Meeting on April 14-18, 2018, in Chicago, Illinois. 

April 12, 20187:15 AM
Conferences

Cancer Advance Boston

On April 12, our chief medical officer, Aiman Shalabi, will be a featured expert on the panel, “Immuno-Oncology: Challenges & Opportunities”.

March 19, 20187:00 AM
Conferences

Fortune Brainstorm HEALTH 2018

Dr. Jill O’Donnell-Tormey, CEO and director of scientific affairs, will participate in the 'Weaponizing Your Own Body' panel on Tuesday, March 20, 2018 at 7:45 am.

February 07, 20187:45 AM
Conferences

2018 Immuno-Oncology 360°

The fourth annual Immuno-Oncology 360° meeting will be held on February 7-9, 2018 at the Roosevelt Hotel, New York City.

January 27, 201810:00 AM
Conferences

Immunotherapy Patient Summit – Houston

This 1-day event in Houston, TX brings together cancer patients, caregivers, and immunotherapy experts to discuss the basics of cancer immunotherapy and the latest developments in cancer research and clinical trials.

January 22, 20184:30 PM
Conferences

Immuno-Oncology Frontiers World

Dr. Vanessa Lucey, associate director, CRI Venture Fund & Clinical Accelerator, is speaking during the "Back to Basics" session on January 23, 2018 at 2:00 p.m. 

January 09, 20187:00 AM
Conferences

ENDPOINTS Executive Breakfast

Aiman Shalabi, Chief Medical Officer, is a panelist at the ENDPOINTS Executive Breakfast in San Francisco. This year's topic: “Where is the cancer R&D revolution headed?”

January 08, 20187:00 AM
Conferences

Biotech Showcase

CRI's CEO and Director of Scientific Affairs, Dr. Jill O’Donnell-Tormey, is a panelist on “IO on the move: New targets, new trends, new combinations” on January 10, 2018.

December 09, 201710:00 AM
Conferences

Immunotherapy Patient Summit – Tampa

This 1-day event in Tampa, FL brings together cancer patients, caregivers, and immunotherapy experts to discuss the basics of cancer immunotherapy and the latest developments in cancer research and clinical trials.

December 07, 201712:00 PM
Conferences

ESMO Immuno Oncology Congress 2017

ESMO Immuno Oncology Congress is a new highly-focused meeting devoted entirely to the development and use of immunotherapies against cancer.

*Immunotherapy results may vary from patient to patient.

Top